Quadrant Capital Group’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Quadrant Capital Group's OGN Position: Q2 2026 in Review
Quadrant Capital Group sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 160 shares — an estimated $959 sold.
Quadrant Capital Group first reported a position in OGN in Q2 2021 and held it in 19 quarters. The position peaked at $803K in Q1 2025. 635 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Quadrant Capital Group reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
- Quadrant Capital Group sold 160 Organon & Co shares in Q2 2026, an estimated $959.
- Quadrant Capital Group first reported a position in Organon & Co in Q2 2021 and held it in 19 quarters.
- Quadrant Capital Group's Organon & Co position peaked at $803K in Q1 2025.
- 635 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.